NEIZA ALVAREZ VALDES: Open Payments
NPI 1891363008 · DORAL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,971 in 94 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $995 · 2025 $1,971
Food & beverage: $1,971
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 16 | $318 |
| Ardelyx, Inc. | 12 | $238 |
| Janssen Biotech, Inc. | 11 | $211 |
| Madrigal Pharmaceuticals | 11 | $199 |
| GENZYME CORPORATION | 9 | $152 |
| Intercept Pharmaceuticals, Inc. | 4 | $113 |
| ABBVIE INC. | 4 | $94 |
| Lilly USA, LLC | 4 | $88 |
| Phathom Pharmaceuticals, Inc. | 3 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
Products named: Sucraid, IBSRELA, TREMFYA, DUPIXENT, REZDIFFRA, OCALIVA, OMVOH, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
